Home · Open Lab · Lot RGX-26-RGNX-1062
RGX-26-RGNX-1062Current
Thymosin Alpha-1 · 5 MG · Immune Research · COA NS-2026-05063

Release test results

99.592%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 5.02 mg
Related impurities (total)0.408%
Endotoxin<1.0 EU/mg
HPLC retention time5 min
MethodHPLC + LC-MS
ResultPass · meets spec
Verify COA at Nordicstar Labs → All certificates

Lot record

CompoundThymosin Alpha-1
Presentation5 MG
Lot numberRGX-26-RGNX-1062
COA numberNS-2026-05063
Test date07 Sep 2026
Release date10 Sep 2026
Independent labNordicstar Labs
StatusCurrent

Thymosin Alpha-1 — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-RGNX-1062 this lot5 MGSep 7, 202699.592%Current
RGX-26-RGNX-106310 MGSep 7, 202699.768%Current
RGX-26-RGNX-63710 MGSep 7, 202699.737%Superseded
RGX-26-RGNX-7385 MGSep 5, 202699.672%Superseded
RGX-26-RGNX-73710 MGSep 5, 202699.699%Superseded
RGX-26-RGNX-6385 MGSep 3, 202699.661%Superseded
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →